塞浦路斯:具有高强度和持久效果的催化细胞外向性蛋白质降解
Zachary R Crook1,2,3, Gregory P Sevilla1,2,3, Pamela Young2
1Cyclera Therapeutics Inc, Seattle, WA 98115, USA. Present address of Z.R.C., G.P.S., and N.W.N.
bioRxiv : the preprint server for biology
|May 7, 2024
概括
CYpHER技术提供了一种新的方法,通过利用pH取决于endolysosomal传递和回收利用向蛋白质降解 (TPD). 这种方法增强了药物的效力,并减少了治疗癌症等疾病的非目标风险.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 传统的抑制剂往往无法解决致病蛋白质的多种致病机制.
- 有针对性的蛋白质降解 (TPD) 提供了一种通过劫持细胞机械来消除疾病蛋白质的策略.
- 现有的TPD策略涉及E3结合酶或内解酶体路径的吸收.
研究的目的:
- 引入CYpHER (CatalYtic pH-dependent Endolysosomal delivery with Recycling) 技术,以提高向蛋白质降解的速度. 为了提高向蛋白质降解的速度.
- 利用一种新的催化机制,将特异性与TPD的模块化设计结合起来.
- 探索CYpHER在提高功效和减少非目标效应方面的潜力.
主要方法:
- CYpHER采用了依赖pH值的释放目标吸引器.
- 它利用快速循环转激素受体 (TfR) 进行细胞吸收.
- 该技术在体外对EGFR和PD-L1进行了验证,在体内对EGFR进行了验证,在非小细胞肺癌模型中对EGFR进行了验证.
主要成果:
- CYpHER 证明了有效的内溶体点传递和药物循环利用.
- 基于TfR的方法可以更轻松地准过度表达TfR的瘤.
- 观察到潜在的中枢神经系统 (CNS) 药物输送.
结论:
- 塞浦路斯的技术提供了一个强大而持久的TPD策略.
- 它的pH依赖和TfR介导的机制在有效性和安全性方面提供了优势.
- 在治疗EGFR驱动的癌症和其他表达TfR的瘤方面,CYpHER显示出前景.
相关概念视频
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome Structure
747
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
747
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K


